FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. What is described is a transdermally absorbable medicinal product containing 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy}benamidine or its salt, and a transdermal absorption enhancer.
EFFECT: transdermally absorbable medicinal product effective in treating fungal infections, possesses a very high ability of for skin penetration and high antifungal activity; and the medicinal product significantly improves the patient's quality of life.
13 cl, 2 dwg, 7 tbl, 58 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RASAGILINE-CONTAINING TRANSDERMAL PLASTER FOR TREATMENT OR PREVENTION OF NERVOUS SYSTEM DISEASES AND METHOD OF ITS PREPARATION | 2007 |
|
RU2379029C1 |
| PERCUTANEOUS ABSORPTION COMPOSITION | 2016 |
|
RU2699674C1 |
| PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY IN CATTLE AND OTHER ANIMALS | 2007 |
|
RU2466715C2 |
| PHARMACEUTICAL COMPOSITION FOR TOPIC APPLICATION | 2008 |
|
RU2468794C2 |
| TRANSDERMAL PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE AGENTS | 2010 |
|
RU2639087C2 |
| LOXOPROFEN-CONTAINING PREPARATION FOR TOPICAL USE | 1997 |
|
RU2173145C2 |
| SKIN COMPOSITION FOR EXTERNAL APPLICATION | 2008 |
|
RU2458678C2 |
| TRANSDERMAL AGENT FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES, METHOD FOR PRODUCTION THEREOF AND COMBINED TRANSDERMAL PREPARATION FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES | 2013 |
|
RU2582278C2 |
| PHARMACEUTICAL PREPARATION OF ABSORPTION TYPE FOR THRANSCUTANEOUS INTRODUCTION | 2006 |
|
RU2396946C2 |
| EXTERNAL PREPARATION | 2020 |
|
RU2814569C2 |
